| 发明名称 |
PREDICTIVE MARKERS USEFUL IN THE TREATMENT OF FRAGILE X SYNDROME (FXS). |
| 摘要 |
<p>The invention is directed to the use of biomarkers to determine responsiveness of an individual with Fragile X Syndrome (FXS) to treatment with an mGluR5 antagonist.</p> |
| 申请公布号 |
MX2012012615(A) |
申请公布日期 |
2012.12.17 |
| 申请号 |
MX20120012615 |
申请日期 |
2011.04.28 |
| 申请人 |
NOVARTIS AG.* |
发明人 |
YUNSHENG HE;JOANNE MEYER;DONALD JOHNS;BALTAZAR GOMEZ-MANCILLA;CHARLES PAULDING |
| 分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
